Free Trial

MBB Public Markets I LLC Takes Position in Humana Inc. $HUM

Humana logo with Medical background

Key Points

  • MBB Public Markets I LLC acquired 1,191 shares of Humana Inc. valued at approximately $315,000 during the 1st quarter, amidst increased interest from several institutional investors.
  • Humana's recent earnings report showed an EPS of $6.27, falling short of analysts' expectations, but its quarterly revenue increased by 9.6% year-over-year.
  • The company announced a quarterly dividend of $0.885 per share, representing an annualized yield of 1.3%, with a payout ratio of 27.17%.
  • Five stocks we like better than Humana.

MBB Public Markets I LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,191 shares of the insurance provider's stock, valued at approximately $315,000.

Other hedge funds also recently bought and sold shares of the company. Cary Street Partners Investment Advisory LLC raised its holdings in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after buying an additional 46 shares during the period. Applied Finance Capital Management LLC raised its holdings in Humana by 1.7% during the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock valued at $779,000 after buying an additional 48 shares during the period. Achmea Investment Management B.V. raised its holdings in Humana by 0.5% during the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock valued at $2,746,000 after buying an additional 49 shares during the period. Beech Hill Advisors Inc. raised its holdings in Humana by 6.1% during the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after buying an additional 50 shares during the period. Finally, Townsquare Capital LLC raised its holdings in Humana by 2.8% during the 1st quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock valued at $597,000 after buying an additional 61 shares during the period. Hedge funds and other institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

HUM has been the topic of several recent research reports. Royal Bank Of Canada increased their price target on Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a report on Thursday, August 21st. Wall Street Zen lowered Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Truist Financial decreased their price target on Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a report on Wednesday, July 16th. Morgan Stanley decreased their price target on Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. Finally, Piper Sandler decreased their price target on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $289.24.

Read Our Latest Research Report on Humana

Humana Trading Down 0.8%

HUM stock traded down $2.36 during midday trading on Friday, reaching $276.36. The company's stock had a trading volume of 1,138,341 shares, compared to its average volume of 1,648,760. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock has a fifty day simple moving average of $265.34 and a two-hundred day simple moving average of $257.18. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $325.75. The firm has a market capitalization of $33.24 billion, a price-to-earnings ratio of 21.21, a PEG ratio of 1.64 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The business had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. During the same quarter in the previous year, the business earned $6.96 EPS. The business's revenue for the quarter was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana's dividend payout ratio (DPR) is currently 27.17%.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Should You Invest $1,000 in Humana Right Now?

Before you consider Humana, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.

While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.